WHAT DOES THIS MEAN FOR PATIENTS? {#sec1}
=================================

In girls and boys, puberty shows up with a variety of signs such as menstrual bleeding, growth spurt, facial and body hair growth, deepening of the voice and breast development. Age at puberty is also related to many medical conditions occurring later in life such as asthma, obesity, cardiovascular diseases and cancer. To identify biological indicators of puberty that could be used for early detection of such medical risks, the researchers investigated DNA-methylation.

DNA-methylation describes a change made to the DNA in genes that does not involve alterations to the DNA sequence itself (epigenetics). Methyl groups are either added to or removed from the DNA, which then alter the function of genes. The researchers explored whether genome-wide changes of DNA methylation between the age of 10 and 18 years can be linked to age of onset of different pubertal events. To this end, the researchers used a large number of children born on the Isle of Wight in the UK (244 girls and 226 boys at either age 10 or 18 years). To exclude false-positive findings, the researchers then checked which DNA-methylation changes had also been found in earlier, smaller studies from Denmark and North America.

The researchers identified 273 DNA-methylation changes in girls and 67 in boys that had also been found in earlier studies, covering 236 and 68 genes, respectively. Most of the genes identified are related to biological processes of puberty; however, in genetic studies only four of the identified genes had previously been linked to pubertal markers in humans. This novel epigenetic information will be used in future studies to investigate which of these markers are risk factors for adult medical conditions and whether they be altered in order to reduce the risk of disease.

Introduction {#sec1a}
============

Puberty is defined as a series of biological and physical transformations initiated by central activation of the hypothalamic--pituitary--gonadal axis ([@ref22]). Pulsatile release of GnRH signals the pituitary gland to secrete the gonadotrophins LH and FSH, and testosterone in females and males, respectively, which trigger the development of secondary sexual characteristics. Age at pubertal onset has been related to a wide variety of conditions including asthma, overweight and obesity, metabolic changes, blood pressure, cardiovascular diseases, stroke, type 2 diabetes, cancer, mortality and psychological well-being in women ([@ref36]; [@ref19]; [@ref78]; [@ref30]; [@ref69]; [@ref79]; [@ref38]; [@ref55]; [@ref39]; [@ref43]; [@ref6]; [@ref28]; [@ref73]; [@ref14]; [@ref26]; [@ref84]; [@ref34]; [@ref46]; [@ref66]; [@ref82]), men ([@ref33]; [@ref53]; [@ref54]; [@ref62]; [@ref66]) or both sexes ([@ref33]; [@ref18]; [@ref50]).

One potential factor regulating the timing of pubertal onset is DNA methylation (DNAm) ([@ref21]; [@ref49]), which is considered to serve as an archive of markers of early developmental exposures, such as maternal smoking. In addition, DNAm may also change as a consequence of pubertal onset and in turn may affect adult diseases. Methylation is a dynamic process of addition of methyl groups to cytosine where cytosine--phosphate--guanine (CpG) dinucleotides occur in the DNA sequence, while demethylation occurs both actively and passively ([@ref16]). Methylation of gene promoter regions is considered to modulate gene expression ([@ref75]), but methylation occurring at other genomic regions (e.g. gene body, intergenic) may also influence transcription ([@ref42]). DNAm also regulates alternative splicing ([@ref60]; [@ref45]), which results in different messenger RNAs and different biological functions ([@ref10]). In girls, precocious puberty has been found to be associated with both increased and decreased methylation levels of different genes ([@ref8]).

There is a need to better understand changes in DNAm following the onset of different pubertal markers such as menarche, thelarche, growth spurt and voice deepening. Hence, a first step is to explore which CpGs can be linked with age of onset of different pubertal events. Two recent longitudinal cohort studies using epigenome-wide analyses investigated associations between puberty timing and DNAm ([@ref2]; [@ref77]). The first study included healthy Danish children, 20 girls and 31 boys, who were examined twice including measurements of DNAm before and after achievement of pubertal Tanner state B2 ([@ref51]; [@ref52]). Testicular volume (≥4 ml) for boys and Tanner breast stage for girls (both indicating a Tanner state of B2 and higher) were utilized as a means of measuring pubertal stage for both genders separately ([@ref2]). When boys and girls were analyzed together while adjusting for age and the different cell counts in analyzed blood samples, the Danish study identified 457 CpGs that changed as a consequence of onset of puberty with a false discovery rate (FDR) of 0.05. Associated methylation levels were either increased or decreased before and after pubertal events. A limitation of the Danish investigation is that the first measurement of DNAm was close to pubertal onset and thus methylation levels may already have been affected by the process of pubertal transition. The second study was based on 30 girls and 25 boys from North America with DNAm measured at 8 and 14 years of age ([@ref77]). Puberty was assessed at both ages by Tanner staging. With separate analyses of girls and boys, the study identified 347 CpGs in girls and 50 CpGs in boys that changed as a consequence of puberty. In addition, 48 differentially methylated CpGs were found in the combined sample of boys and girls. The [@ref77]) study did not adjust for age at sample collection or cell composition of the samples drawn at 8 and 14 years. Thus, some DNAm changes could be related to aging but not pubertal changes. Moreover, not adjusting for cell composition, which is likely to change between 8 and 14 years, may have led to some CpGs remaining undetected.

Since age at menarche is not part of the Tanner's Sexual Maturation Scale ([@ref51]; [@ref52]), information on age at menarche, a frequently used indicator of puberty in girls ([@ref40]), also in genetic studies ([@ref24]; [@ref63]; [@ref80]), was not assessed in the above investigations. As genome-wide associations explain only 2.7% of the variance of age at menarche ([@ref63]), it is important to explore whether DNAm could be associated with age at menarche.

We previously investigated variables collected by the Pubertal Development Scale (PDS) ([@ref65]) for association with child growth ([@ref86]). In this study, based on a larger birth cohort of children born on the Isle of Wight (IoW) in the UK (244 girls and 226 boys at either age 10 or 18 years), we investigated whether ages of pubertal events are associated with DNAm at 10 and 18 years. To this end, we used the age of onset of different pubertal events ([@ref11]). Since puberty-related processes vary among girls and boys, we conducted separate analyses for both sexes and adjusted for age and cell composition of the DNAm collected at both ages, 10 and 18 years. We identified CpGs, and their respective genes, that are associated with age of different pubertal markers. In addition, we compared our findings with those published by [@ref2] and [@ref77]. Finally, we identified biological pathways represented by the genes whose CpGs gained statistical significance.

Materials and Methods {#sec2}
=====================

Data analyzed in this study were from a birth cohort composed of children born between 1 January 1989 and 28 February 1990 on the IoW, UK ([@ref3]). The IoW is a semi-rural island located close to the British mainland. Of the 1536 children born in this period, 1456 were recruited, and 1313 participated in both follow-ups at ages 10 and 18 years. In subsamples of these children, DNAm was measured at ages 10 and 18 years.

Assessment of puberty {#sec3}
---------------------

The National Institute of Child and Human Development (NICHD) questionnaire from the Study of Early Child Care and Youth Development based on the PDS was used ([@ref65]). At age 18 years, children self-reported their development using five markers of pubertal growth. Both genders were asked about ages of onset of growth spurt, body hair growth and skin changes. Ages at voice deepening and growth of facial hair were inquired from boys, while ages at breast development and menarche were reported by girls. Since we asked 18-year-old participants, we focused on ages of onset which is a subpart of the five questions of the NICHD questionnaire ([@ref86]). Ages at which pubertal events occurred were provided as years in whole numbers (i.e. age 13 years).

The varying ages of onset of a specific pubertal event provide unique pubertal timing information in relation to DNAm measurements. For instance, if a girl's first period occurs at age 12 years, then DNAm measurement at age 10 is 2 years before onset of menarche; DNAm measurement at 18 years is 6 years later ([Fig. 1](#f1){ref-type="fig"}). If another girl's first period occurs at age 17 years, then DNAm measurement at age 10 and 18 is 7 years before and 1 year after, respectively ([Fig. 1](#f1){ref-type="fig"}). Although DNAm was measured at the same chronological age, 10 and 18 years, the timing of puberty in relation to DNAm measurements of both girls is different (−2 and +6 in the first girl, −7 and +1 in the second). In our statistical analyses, we followed the approach by [@ref2] by using the difference in years of the age at methylation assessment and age at pubertal onset (Δyears) for identification of differential CpG methylation. For example, in our repeated measurement analysis, −2 and +6 were used as differences in time (Δyears) between DNAm measurement and onset of specific pubertal markers ([Fig. 1](#f1){ref-type="fig"}). Using repeated DNAm measurements and their differences to pubertal age allowed us to integrate ages at pubertal events that occurred before the first DNAm measurement at age 10 years (e.g. when breast development started at age 8 years).

DNA methylation analysis {#sec4}
------------------------

Blood samples were collected at ages 10 and 18 years. DNA was extracted using a standard salting out procedure ([@ref56]). DNA concentration was estimated by fluorometric quantitation. The methylation level for each CpG site was assessed using one of two platforms, the Illumina Infinium HumanMethylation450 BeadChip (Illumina, Inc., San Diego, CA, USA) or the Infinium MethylationEPIC BeadChip (Illumina, Inc., San Diego, CA, USA). For each sample, 1 μg of DNA was bisulfite-treated for cytosine to thymine conversion using the EZ-96 DNA methylation kit (Zymo Research, Irvine, CA, USA), following the manufacturer's protocol. HumanMethylation450 BeadChip interrogates \>484 000 CpGs and MethylationEPIC BeadChip \>850 000 CpGs, both associated with over 24 000 genes. Arrays were processed using a standard protocol ([@ref9]) with multiple identical control samples assigned to each bisulfite conversion batch to assess array variability. DNA samples were randomly distributed on the arrays, aiming to eliminate batch effects. DNAm was measured by a ratio of intensities, denoted as *β* values for each CpG site, which is a ratio of methylated (*M*) over the sum of methylated and unmethylated (*U*) probes (*β* = *M*/\[*c* + *M* + *U*\]), where *c* is used as a constant to prevent zero in the denominator. *M* values were calculated via log2(*β*/(1−*β*)), which better approximate a normal distribution.

### Methylation data at age 10 and 18 years {#sec5}

Quality control was undertaken and quantile normalized beta values were processed following the CPACOR pipeline ([@ref44]) from a total of seven batches---two from 450K and five from the EPIC array platform (DNAm samples at 10 years) and six batches---two from 450K and four from the EPIC array platform (DNAm samples at age 18 years). These samples from different array platforms and batches were combined, and only the shared probes between EPIC and 450K arrays were included. In both the 10- and 18-year methylation data, the R package *ComBat* ([@ref41]) was used to remove the batch effect in the combined dataset. CpG sites with probe-single nucleotide polymorphisms within 10 base pairs and with a minor allele frequency greater than 0.007 in the Caucasian population (which represented \~10 subjects expected in the sample of this study cohort) were excluded. In total, 349 455 CpG sites from a total 470 participants (*n* = 322 at age 10 and *n* = 465 at age 18 years) with pubertal information were available for analysis.

### Cell type proportions {#sec6}

The *estimateCellCounts()* function from the Minfi package ([@ref4]) using the adult reference panel ([@ref68]) and the method by [@ref88] and [@ref87] was utilized to estimate cell proportions for each sample at each age (10 and 18 years). White blood cell counts (CD4T, CD8T, natural killer cells, B cells, monocytes, granulocytes and eosinophils) were estimated using DNAm data of separate platforms (450 k and EPIC) and then combined.

![**Examples of ages of pubertal onset, age at DNA-methylation measurements and time differences between pubertal onset and DNA-methylation assessment used in repeated measurement analyses (girl 1: −2, +6 years; girl 2: −7, +1 years)**.](hoaa006f1){#f1}

Analytical design {#sec7}
-----------------

Using epigenome-wide DNAm data to identify differentially methylated CpGs that were associated with the onset of the five pubertal events, we applied linear mixed models with repeated methylation measurements of individual CpGs (dependent variable) determined at age 10 (*n* = 322) and 18 years (*n* = 465). Following Almstrup's approach ([@ref2]), the differences in years between the age of puberty onset and the age of DNAm measurements ([Fig. 1](#f1){ref-type="fig"}) were used as independent variables (Δyears). Analyses were run separately for girls and boys. The analysis was not restricted to paired data (DNAm measured at 10 and 18 years), since missing DNAm data at one age does not result in exclusion of observations in linear mixed models. To adjust for methylation changes that are simply due to the chronological age, the methylation of 349 455 CpGs was first regressed on age of DNAm measurement using *M* values. Then, the residual methylations not explained by age were regressed in the linear mixed models on differences in years (Δyears). For each pubertal event (body hair growth, breast growth, menarche, skin changes and growth spurt in girls and body hair growth, facial hair growth, voice deepening, skin changes and growth spurt in boys), the residual methylations and Δyears were modeled as follows:$$\documentclass[12pt]{minimal}
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}{}${\varepsilon}_{ij}$\end{document}$ is the error term. To adjust for cell composition at each period (age 10 and age 18 years), cell proportions were added into the model as covariates. To prevent a large proportion of false positives ([@ref7]) resulting from 349 455 tests and a *P* value on 0.05, we controlled for the FDR to correct for multiple tests. *P* values of the genome-wide association studies, stratified by gender, are illustrated using Manhattan plots. Volcano plots were used to show the extent of positive or negative associations between methylation of CpGs and Δyears. Next, findings were compared with those of a Danish and a North American study ([@ref2]; [@ref77]). Among the 453 CpGs provided by Almstrup *et al*. (personal communication), 389 were found among the 349 455 CpGs in the IoW cohort. [@ref77] identified 347 CpGs in girls and 50 in boys, of which 288 for girls and 43 for boys were available for analysis in the IoW dataset. The analyses were performed using the R package (Vienna, Austria) and SAS version 9.4 (Cary, NC, USA). Finally, we investigated biological pathways for the genes of those CpGs that were replicated in either study, using the ToppFun server (<http://toppgene.cchmc.org/enrichment.jsp>) ([@ref15]) as a functional annotation tool. To this end, we first annotated the CpGs to their corresponding gene names by using the Infinium MethylationEPIC v1.0 B4 Manifest File. We found the nearest gene names using Snipper v1.2 (<https://csg.sph.umich.edu/boehnke/snipper/>) for the CpGs that had no gene names in the EPIC manifest file.

Results {#sec8}
=======

With respect to sex and socioeconomic status, there was no statistically significant difference between the 1313 offspring who were followed up at age 18 years and the 470 adolescents who had information on both ages at pubertal events and DNAm at age 10 or 18 years. ([Table I](#TB1){ref-type="table"}).

###### 

Comparison of all participants in the Isle of Wight birth cohort at 18 years and those with information on age of pubertal onset and DNA methylation at 10 or 18 years.

  Variable                              Total sample at age 18 years (*n* = 1313), %   Sample with puberty data and DNA methylation (*n* = 470), %   *P* value chi-square test
  ------------------------------------- ---------------------------------------------- ------------------------------------------------------------- ---------------------------
  Sex (girls)                           50.3                                           51.9                                                          0.37
  Socioeconomic status of the parents                                                                                                                0.87
   Low                                  14.4                                           15.0                                                          
   Medium                               77.3                                           76.5                                                          
   High                                 8.4                                            8.5                                                           
  Participation at age 18 yrs                                                                                                                        \<0.0001
   In person                            65.8                                           97.7                                                          
   By telephone                         32.1                                           2.3                                                           
   By mail                              2.1                                            0                                                             
  Still in education at age 18 years    69.8                                           77.9                                                          \<0.0001

At age 18 years, puberty information was collected from subjects through in-person visits (843 of 864, 97.6% provided puberty information), telephone interviews (391/421, 92.9% with puberty information) or mailed questionnaires (27/28, 96.4% with puberty information). Of the 470 participants with pubertal and DNAm information at ages 10 or 18 years, 226 were boys and 244 were girls. In total, 322 participants had pubertal information and DNAm at age 10 years, and 465 at age 18 years. In girls, ages at menarche, breast growth and body hair growth were recalled by most participants ([Table II](#TB2){ref-type="table"}). In boys, ages at facial hair growth and deepening of the voice were questions with a larger number of recalls. Regarding growth spurt, body hair growth and skin change, girls started about 1 year earlier than their male counterparts. The ages of onset of different puberty events were significantly correlated among boys and girls. All puberty variables had high internal consistency; the overall raw Cronbach's alpha coefficient was 0.80 in boys and 0.86 in girls ([@ref86]).

###### 

Age of onset of pubertal events in girls and boys.

                                   Observations with methylation at age 10 or 18 years (*n*)   Mean (years)   Median (years)   SD     Minimum (years)   Maximum (years)
  ------- ------------------------ ----------------------------------------------------------- -------------- ---------------- ------ ----------------- -----------------
  Girls   Growth spurt             194                                                         12.4           12               1.82   5                 16
          Body hair growth         230                                                         12.2           12               1.45   7                 16
          Skin changes             176                                                         13.1           13               1.59   9                 17
          Breast growth            230                                                         12.3           12               1.59   8                 16
          Age at menarche          237                                                         12.3           13               1.36   9                 17
  Boys    Growth spurt             204                                                         13.5           14               1.65   7                 16
          Body hair growth         214                                                         13.3           13               1.4    8                 17
          Skin changes             179                                                         13.9           14               1.3    10                18
          Deepening of the voice   218                                                         14.1           14               1.2    10                17
          Facial hair growth       223                                                         15.3           15               1.12   11                18

We identified more CpGs that were significantly changed related to age at puberty in girls than in boys ([Figs 2](#f2){ref-type="fig"} and [3](#f3){ref-type="fig"}). [@ref2]) did not provide gender-specific CpGs associated with pubertal events; hence, we included the CpGs identified by them in the Manhattan plots of both sexes ([Fig. 2](#f2){ref-type="fig"}). For girls, [Fig. 2](#f2){ref-type="fig"} shows that we determined more significantly associated CpGs than the two prior studies, in particular for *P* values of less than e^−10^. In boys, the Manhattan plot using the IoW data demonstrates more significant gender-specific CpGs than Thompson (blue triangles). Since Almstrup did not separate gender-specific associations, the red dots in the Manhattan plot for boys may present CpGs related to puberty in both genders.

![**Manhattan plot of the CpGs related to age at pubertal onset.** Manhattan plot shows the CpGs related to ages of pubertal onset in the Isle of Wight (IoW) birth cohort (gray and yellow dots) including a plot of the statistical significant CpGs determined in the IoW study replicated by [@ref2] or [@ref77]. The black diamonds in the Manhattan plot are the CpGs identified in the IoW study and replicated in either [@ref2] or [@ref77]. The red dots are CpGs identified as statistically significant by Almstrup *et al*. but not our study; the blue triangles were detected by Thompson *et al*. but not our study. The dashed black line represents a false discovery rate (FDR) *P* value of 0.05; the solid red line presents a *P* value of 1 e^−10^, and the solid violet line gives the lower limit of 2.44 e^−13^. The gray and yellow dots above the dashed black line characterize CpGs identified in the IoW study but not replicated by either Almstrup *et al*. or Thompson *et al*. ([@ref2], [@ref77]). Note: The negative log of adjusted *P* values on the *Y*-axis stretches the scale and makes it easier to visualize the significant CpGs.](hoaa006f2){#f2}

![**Venn diagram of the number of CpGs associated with changes at puberty.** The diagram shows the number of CpGs associated with ages of changes of body hair, and skin, growth spurt, breast growth (girls), menarche (girls), facial hair (boy) and deepening of the voice (boy) at a FDR cut-off *P* value of 0.05 in boys and girls.](hoaa006f3){#f3}

Separately for girl and boys, the Venn diagram ([Fig. 3](#f3){ref-type="fig"}) characterizes CpG detected with a FDR *P* value \<0.05 for each event and their overlap. In girls, a total of 63 019 CpGs changed related to any of the five pubertal ages and 13 487 were associated with all five ages. The number of CpGs that changed related to age at menarche is largest. Age at menarche also shows the largest overlap of detected CpGs with age at breast development, body hair growth and skin changes. In boys, the total and overlapping numbers of CpGs among the five pubertal events are 3072 and 311 CpGs, respectively, and are much smaller. The largest overlap in boys is seen for facial hair growth and deepening of the voice. In total, we identified more CpGs significantly related to any puberty event in girls than in boys (gray and yellow dots in [Figs 2](#f2){ref-type="fig"} and [3](#f3){ref-type="fig"}). To investigate overestimations of statistical significance due to inflation of test statistics in this epigenome-wide study, we used *Q*--*Q* plots and the genomic inflation factor ([@ref35]). Except for age at menarche (inflation factor = 1.13), all other inflation factors for the ages at pubertal events were below 1, indicating that all our reported findings were not inflated and no adjustment was necessary. Regarding age at menarche, an inflation factor of 1.13 indicates only a minor inflation of results.

Inspecting the directions of effects and strength of the regression coefficients using volcano plots shows that there are equal numbers of positive and negative effects of puberty on methylation in boys and girls ([Supplementary Fig. S1](#sup1){ref-type="supplementary-material"}). However, there are many more CpGs in girls strongly linked to Δyears than in boys. A positive coefficient between Δyears and DNAm at ages 10 or 18 years means that the puberty event is related to an increase in DNAm over time. A negative coefficient describes methylation levels that are higher prior to the experience of puberty and decrease thereafter. [Supplementary Figs S2](#sup2){ref-type="supplementary-material"} and [S3](#sup3){ref-type="supplementary-material"} each provide four examples, two CpGs for each gender, showing an increase and decrease in DNAm over Δyears, with and without adjustment for blood cell composition.

In total we tested 349 455 CpGs measured at 10 and 18 years of age ([Table III](#TB3){ref-type="table"}). In the analysis, we used the distance of pubertal onsets relative to 10 and 18 years (Δyears) and residual DNAm (adjusted for age of DNA methylation measurements) and controlled for cell composition. [Table III](#TB3){ref-type="table"} shows that the majority of statistically significant CpGs were associated with age of menarche (*k* = 55 230) in girls and facial hair growth in boys (*k* = 2524). In girls, 18% of all CpGs were statistically significantly associated with age of at least one pubertal event and 8.8% in boys (FDR *P* value ≤0.05). In girls, 3.9% of the CpGs showed a differential methylation for all five events, and 0.089% in boys. [@ref2] provided 453 statistically significant CpGs (FDR ≤ 0.05) from the combined samples of 51 boys and girls. After data cleaning, we found 389 of these CpGs in our list of 349 455 CpGs. In the sample of 55 North American adolescents, [@ref77] reported 347 statistically significant CpGs in girls and 50 in boys, of which 288 CpGs in girls and 43 CpGs in boys, respectively, are available in our IoW data as shown in the flowchart ([Fig. 4](#f4){ref-type="fig"}). Hence, for girls, the two previous studies provided 745 statistically significant CpGs, of which 629 CpGs are available in our IoW data (288 CpGs from [@ref77] combined with 389 CpGs gender-unspecific CpGs from Almstrup *et al*., excluding those CpGs identified by both investigations). In boys, a total of 496 individual CpGs were detected by the two studies ([Fig. 4](#f4){ref-type="fig"}), of which 425 CpGs are available in the IoW data (43 from Thompson *et al*. and 389 gender-unspecific CpGs from Almstrup *et al*., after excluding those CpGs identified by both investigations and those not available in the IoW data). Of these 629 and 425 in girls and boys, respectively, we detected 43.4 and 15.8% as statistically significant related to at least one pubertal event ([Fig. 4](#f4){ref-type="fig"}).

###### 

Number of CpGs significantly associated with pubertal events based on analysis of 349 455 CpGs.

  Sex             Age at:           Number of significant CpGs associated with each event   Number of CpGs significantly associated with at least one pubertal event (% of 349 455 CpGs)   Number of CpGs significantly associated with all five pubertal events (% of 349 455 CpGs)   Number of significant CpGs (at least one event) that overlapped with those detected by [@ref2] or [@ref77]   Number of significant CpGs (all five events) that overlapped with those detected by [@ref2] or [@ref77]
  ------- ------------------------ ------------------------------------------------------- ---------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------ ---------------------------------------------------------------------------------------------------------
  Girls         Growth spurt                               18 108                                                                  63 019 (18.0)                                                                                 13 487 (3.86)                                                                  273 (43.4% of 629 CpGs detected by Almstrup or Thompson)                                                   112 (17.8% of 629 CpGs detected by Almstrup or Thompson)
              Body hair growth                             40 242                                                                                                                                                                                                                                                                                                                                  
                Skin changes                               28 237                                                                                                                                                                                                                                                                                                                                  
               Breast growth                               32 155                                                                                                                                                                                                                                                                                                                                  
                  Menarche                                 55 230                                                                                                                                                                                                                                                                                                                                  
  Boys          Growth spurt                                 534                                                                     3072 (8.8)                                                                                   311 (0.089)                                                                   67 (15.8% of 425 CpGs detected by Almstrup or Thompson)                                                     10 (2.3% of 425 CpGs detected by Almstrup or Thompson)
              Body hair growth                              1769                                                                                                                                                                                                                                                                                                                                   
                Skin change                                  901                                                                                                                                                                                                                                                                                                                                   
           Deepening of the voice                           2217                                                                                                                                                                                                                                                                                                                                   
             Facial hair growth                             2524                                                                                                                                                                                                                                                                                                                                   

![**Flowchart of the replication approach addressing the number of available and statistically significant CpGs in three different studies, for girls and boys separately.** The flow chart is for the present study, [@ref77] and [@ref2].](hoaa006f4){#f4}

[Tables IV](#TB4){ref-type="table"} and [V](#TB5){ref-type="table"} show the top 50 most significant and replicated CpGs associated with Δyears among the five pubertal events. The respective FDR-adjusted *P* value ranges from e^−13^ to e^−5^ in girls and from e^−4^ to 0.03 in boys. [Supplementary Tables SI](#sup4){ref-type="supplementary-material"} and [SII](#sup5){ref-type="supplementary-material"} provide all significant and replicated CpGs (273 CpGs in girls and 67 in boys) with details such as pubertal event and regression coefficients. In total, we identified 236 genes in girls and 68 genes in boys (at least one CpG was related to two gene names). The CpGs are almost evenly distributed across all chromosomes.
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  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  CpG           Highest absolute *t* value   Smallest *P* value   *P* value after FDR adjustment   Chr      Gene name        MapInfo     UCSC ref gene group   Relation to UCSC CpG island
  ------------ ---------------------------- -------------------- -------------------------------- ----- ----------------- ------------- --------------------- -----------------------------
  cg18369972               8.09                   6.7E-16                    5.9E-13               17         GAS7          9 940 121       Body; TSS200      

  cg09037630               7.99                   1.3E-15                    1.0E-12                6        NFKBIL1       31 528 239                         

  cg08129129              −7.71                   1.3E-14                    7.3E-12               14        BCL11B        99 714 031           Body                     S_Shore

  cg02387618              −7.19                   6.4E-13                    2.0E-10                5         TCF7         133 453 480          Body                     S_Shelf

  cg05895618               7.18                   7.1E-13                    2.3E-10               11         CSRP3        19 222 395           5′UTR         

  cg26207239              −7.13                   1.0E-12                    3.1E-10               11         BIRC2        102 231 936          Body          

  cg07168526               7.00                   2.5E-12                    9.4E-10                7          ST7         116 797 907          Body          

  cg06881914               6.94                   4.0E-12                    9.8E-10               11        MS4A6A        59 951 663          TSS1500        

  cg05087455               6.83                   8.7E-12                    2.0E-09                2        RNF144A        7 171 869           Body                     N_Shore

  cg10403394               6.84                   8.2E-12                    2.6E-09               15         TPM1         63 349 192           Body          

  cg03834031               6.82                   8.9E-12                    2.8E-09               22      MIRLET7BHG      46 465 717                                    N_Shore

  cg09248660               6.70                   2.1E-11                    4.3E-09                6        RIPOR2        24 969 848                         

  cg08059678              −6.66                   2.7E-11                    5.4E-09               16         VAC14        70 728 425           Body          

  cg23368715               6.62                   3.7E-11                    7.0E-09               12          C1R          7 245 510          TSS1500        

  cg08486432              −6.57                   4.9E-11                    9.0E-09                6         ITPR3        33 598 003           Body                     N_Shelf

  cg00259097              −6.47                   9.6E-11                    1.6E-08               16         VAC14        70 770 604           Body          

  cg24403644              −6.36                   2.1E-10                    3.2E-08               20         TOX2         42 574 624          5′UTR;\        
                                                                                                                                            Body; 1stExon     

  cg06740227               6.55                   5.6E-11                    3.3E-08               12        RASSF9        86 229 804           Body          

  cg09437994              −6.38                   1.7E-10                    3.4E-08               16        CBFA2T3       89 035 147           Body                     S_Shore

  cg15302376              −6.19                   6.1E-10                    8.3E-08                2        DNMT3A        25 560 263           5′UTR                    N_Shelf

  cg27364319               6.19                   6.1E-10                    8.3E-08               12         RARG         53 626 837          TSS1500                   S_Shore

  cg01538166               6.21                   5.3E-10                    8.9E-08               17        SREBF1        17 743 987                                    Island

  cg22460123               6.15                   8.0E-10                    1.0E-07               12         KRT7         52 638 294           Body                     N_Shore

  cg03042633              −6.09                   1.1E-09                    1.4E-07                1          SKI          2 183 365           Body          

  cg24681499              −6.05                   1.4E-09                    1.7E-07                1         FOXJ3        42 706 997           Body          

  cg00476955               6.05                   1.5E-09                    2.2E-07               11         TRPC2         3 648 013           Body          

  cg03193328               6.01                   1.9E-09                    2.2E-07                7         TPST1        65 746 852           Body          

  cg14215711               6.00                   2.0E-09                    2.3E-07               10        PIP4K2A       22 894 054           Body          

  cg27205928              −5.86                   4.7E-09                    4.9E-07                7        C7orf50        1 062 652           Body                     Island

  cg09258479               5.84                   5.2E-09                    6.5E-07                1       PDZK1IP1       47 655 861          TSS200         

  cg26580413               5.80                   6.6E-09                    6.9E-07               16          FTO         54 025 348           Body          

  cg10104487               5.78                   7.4E-09                    7.1E-07                1         TRNP1        27 329 335                                    N_Shelf

  cg25936358               5.77                   7.8E-09                    9.3E-07               13         ATP4B        114 301 996                                   N_Shore

  cg06437747               5.72                   1.1E-08                    1.2E-06                1        ACTRT2         2 890 836                                    S_Shelf

  cg14980020              −5.65                   1.6E-08                    1.4E-06                1         DCST2        154 992 262          Body                     S_Shelf

  cg11442608               5.64                   1.7E-08                    1.8E-06               15        CFAP161       81 456 832                         

  cg16335893              −5.45                   5.1E-08                    3.8E-06               12       MPHOSPH9       123 634 159                                   N_Shore

  cg07396746               5.43                   5.6E-08                    4.1E-06                8         LOXL2        23 162 295           Body          

  cg10566581              −5.40                   6.8E-08                    4.9E-06               20         TGIF2        35 220 415           3'UTR         

  cg20770512               5.34                   9.4E-08                    6.3E-06                6         GFOD1        13 396 094           Body          

  cg15626881               5.30                   1.2E-07                    9.3E-06                7         BMPER        33 923 464                         

  cg05584950               5.25                   1.5E-07                    9.5E-06                2         ATOH8        86 012 847           Body          

  cg04586023               5.25                   1.6E-07                    1.2E-05               22        HDAC10        50 690 380          TSS1500                   S_Shore

  cg01750375               5.21                   1.9E-07                    1.5E-05               20         WISP2        43 343 365          TSS1500        

  cg00374672               5.12                   3.0E-07                    1.7E-05                7        SLC12A9       100 463 416          Body                     N_Shore

  cg17220749              −5.09                   3.5E-07                    1.9E-05                1        GALNT2        230 249 292          Body          

  cg01282174               5.07                   3.9E-07                    2.1E-05               11         PVRL1        119 630 144                        

  cg09492074               5.23                   1.7E-07                    2.2E-05               15        MEGF11        66 263 624           Body          

  cg22740489               5.00                   5.8E-07                    3.0E-05                2    LIMS3-LOC440895   110 706 159          Body                     S_Shore

  cg18451156              −4.99                   6.2E-07                    3.1E-05               12         CHFR         133 424 373          Body          
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^\*^Since these CpGs represent the overlap of association with five events, the lowest *P* values identified for several outcomes is shown. UCSC: University of California Santa Cruz, Chr: chromosome, FDR: false discovery rate.
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}{}$\Delta$\end{document}$years of body hair and facial hair growth, deepening of the voice, skin changes and/or growth spurt in boys.

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  CpG          Highest *t* value among five events   Smallest *P* value   *P* value after FDR adjustment   Chr   Gene name   MapInfo       UCSC ref gene group   Relation to UCSC CpG island
  ------------ ------------------------------------- -------------------- -------------------------------- ----- ----------- ------------- --------------------- -----------------------------
  cg16163419   −5.70                                 1.2E-08              2.1E-04                          3     ABI3BP      100 712 326   5′UTR;\               
                                                                                                                                           1stExon               

  cg21899500   5.13                                  2.9E-07              7.9E-04                          3     GRM2        51 740 850    TSS1500               Island

  cg21213853   5.02                                  5.1E-07              1.0E-03                          3     GRM2        51 741 473    5′UTR                 S_Shore

  cg07547765   5.19                                  2.1E-07              1.2E-03                          17    HOXB7       46 685 448    Body                  Island

  cg06740227   −4.95                                 7.3E-07              1.2E-03                          12    RASSF9      86 229 804    Body                  

  cg25460807   5.02                                  5.1E-07              1.3E-03                          8     FGF17       21 908 022                          S_Shelf

  cg08220120   4.94                                  7.9E-07              1.7E-03                          5     LOC389333   138 727 711   1stExon;3′UTR         Island

  cg13274149   4.82                                  1.4E-06              1.8E-03                          9     C9orf167    140 175 393   3'UTR                 Island

  cg16867657   5.09                                  3.6E-07              1.9E-03                          6     ELOVL2      11 044 877    TSS1500               Island

  cg21878650   −4.82                                 1.5E-06              2.2E-03                          5     ADAMTS6     64 558 623    Body                  

  cg07164639   −4.78                                 1.8E-06              2.4E-03                          6     DDO         110 736 958   TSS1500               

  cg11743675   4.72                                  2.3E-06              2.9E-03                          12    CNTN1       41 221 855    5′UTR                 

  cg06942979   4.71                                  2.5E-06              3.0E-03                          22    SELM        31 501 382    Body                  N_Shore

  cg11041817   4.67                                  3.1E-06              3.4E-03                          17    HOXB7       46 685 327    Body                  Island

  cg25711003   −4.65                                 3.3E-06              3.5E-03                          3     PHLDB2;\    111 522 050   5′UTR;\               
                                                                                                                 PLCXD2                    Body                  

  cg16980380   4.71                                  2.5E-06              3.9E-03                          17    ENDOV       78 417 883                          Island

  cg18773260   4.92                                  8.4E-07              4.1E-03                          17    HOXB7       46 685 292    Body                  Island

  cg00303541   4.49                                  7.1E-06              4.5E-03                          3     GRM2        51 741 280    5′UTR                 Island

  cg09809672   −4.50                                 6.8E-06              4.9E-03                          1     EDARADD     236 557 682   TSS1500;5′UTR;\       N_Shore
                                                                                                                                           1stExon               

  cg21101631   4.90                                  9.4E-07              5.8E-03                          5     PCDHGA4;\   140 874 572   Body                  S_Shelf
                                                                                                                 PCDHGC3;                                        

  cg25693132   4.40                                  1.1E-05              7.3E-03                          3     GRM2        51 740 741    TSS1500               Island

  cg02489552   4.36                                  1.3E-05              7.4E-03                          19    CCDC105     15 121 531    TSS200                N_Shore

  cg06783429   4.35                                  1.4E-05              7.5E-03                          7     SND1        127 673 038   Body                  S_Shore

  cg25150953   −4.34                                 1.4E-05              7.6E-03                          4     LIMCH1      41 540 229    Body                  

  cg01331772   4.33                                  1.5E-05              7.9E-03                          2                 131 094 827                         

  cg21572722   4.38                                  1.2E-05              8.3E-03                          6     ELOVL2      11 044 894    TSS1500               Island

  cg15028548   −4.31                                 1.7E-05              8.4E-03                          3     ABI3BP      100 712 322   5′UTR;\               
                                                                                                                                           1stExon               

  cg09143195   −4.30                                 1.7E-05              8.5E-03                          12    CNTN1       41 085 901    TSS1500               N_Shore

  cg03131366   −4.27                                 2.0E-05              9.4E-03                          12                2 041 707                           

  cg01883408   4.25                                  2.1E-05              1.0E-02                          5     CCNI2       132 083 691   Body                  Island

  cg00700412   4.22                                  2.4E-05              1.1E-02                          12                58 011 837                          N_Shore

  cg19270739   −4.28                                 1.9E-05              1.1E-02                          1                 1 368 846                           N_Shore

  cg03994651   4.15                                  3.3E-05              1.2E-02                          19    LMTK3       49 004 677    Body                  Island

  cg18055623   4.16                                  3.2E-05              1.3E-02                          19    CACNG8;\    54 485 327    Body;\                Island
                                                                                                                 MIR935                    TSS1500               

  cg05694021   −4.15                                 3.4E-05              1.3E-02                          12                19 699 504                          

  cg05697274   4.14                                  3.4E-05              1.3E-02                          1     GALNT2      230 415 377   3′UTR                 Island

  cg27033805   −4.11                                 3.9E-05              1.4E-02                          8     BOP1        145 499 436   Body                  S_Shore

  cg16387850   4.09                                  4.3E-05              1.5E-02                          1                 46 982 889                          

  cg13138089   4.05                                  5.2E-05              1.7E-02                          2     ECEL1P2     233 251 770   TSS200                Island

  cg06443034   4.38                                  1.2E-05              1.8E-02                          17                78 417 973                          Island

  cg01426818   4.31                                  1.6E-05              2.0E-02                          17                77 806 444                          Island

  cg13392258   3.97                                  7.1E-05              2.0E-02                          17                77 806 190                          Island

  cg19022697   3.92                                  8.9E-05              2.0E-02                          1     TTC22       55 247 140    Body                  Island

  cg02231404   4.15                                  3.3E-05              2.1E-02                          20    SOX18       62 679 635    Body                  Island

  cg02046143   −3.95                                 7.9E-05              2.2E-02                          11    IGSF9B      133 797 911   Body                  N_Shelf

  cg15840151   3.89                                  1.0E-04              2.5E-02                          10    C10orf120   124 459 681   TSS1500               

  cg21968765   −3.88                                 1.1E-04              2.5E-02                          3     ABI3BP      100 712 345   TSS200                

  cg11766468   4.16                                  3.2E-05              2.7E-02                          19    EVI5L       7 923 041     Body                  N_Shelf

  cg22398226   3.81                                  1.4E-04              3.0E-02                          4                 155 662 217                         N_Shore

  cg19344626   −3.80                                 1.4E-04              3.1E-02                          19    NWD1        16 830 749    TSS200                
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

^\*^Since these CpGs represent the overlap of association with five events, the lowest p-values identified for several outcomes is shown.

In girls, the identified 273 CpGs represent 236 genes ([Supplementary Table SI](#sup4){ref-type="supplementary-material"}). Inspecting biological processes (European Bioinformatics Institute---[https://www.ebi.ac.uk/](https://www.ebi.ac.uk/).)) related to the revealed genes using as a functional annotation tool the ToppFun server ([@ref15]), showed 11 biological processes ([Supplementary Table SIII](#sup6){ref-type="supplementary-material"}). The 11 biological processes are related to growth and pubertal changes and can be grouped into five developments: bones (bone development GO:0060348, endochondral bone morphogenesis (GO:0060350), bone morphogenesis (GO:0060349)); related to adhesion (cell adhesion (GO:0007155), and biological adhesion (GO:0022610)); related to neural changes (neurogenesis (GO:0022008), neuron differentiation (GO:0030182), retina layer formation (GO:0010842), and retina development in camera-type eye (GO:0060041)); related to anatomical structure formation involved in morphogenesis (GO:0048646, which describes the initial formation of an anatomical structure from unspecified parts); and responses to progesterone (GO:0032570, which characterizes a change in activity as a result of a progesterone stimulus). The identification of these biological processes in girls provides credibility for the 273 puberty-related CpGs that were also replicated in at least one of the two other studies.

Of the genes in boys replicated by either of the previous studies ([@ref2]; [@ref77]), functional annotation analysis showed no significant biological processes for boys using 68 genes of 67 CpGs ([Supplementary Table SII](#sup5){ref-type="supplementary-material"}). However, to inspect individual genes, we then focused on genes whose CpGs were related to at least two pubertal events ([Supplementary Table SIV](#sup7){ref-type="supplementary-material"}) \[number of events\] (*ABI3BP* \[5\], *CBX4* \[3\], *CNTN1* \[3\], *DDO* \[3\], *ELOVL2* \[5\], *GRM2* \[5\], *HOXB7* \[5\], *KCNAB3* \[3\], and *LIMCH1* \[2\]).

Discussion {#sec9}
==========

In agreement with recent reports that epigenetic changes are crucial in the development of puberty ([@ref49]), we identified a large number of DNA methylation changes related to puberty. In 244 girls and 226 boys, we identified more CpGs in girls significantly linked with ages at all five pubertal events (*k* = 13 487) than in boys (*k* = 311). Of these, 273 CpGs in girls and 67 CpGs in boys were also identified previously ([@ref2]; [@ref77]). In other words, of the 629 and 425 found in girls and boys, respectively, in prior studies ([Fig. 4](#f4){ref-type="fig"}), we detected 43.4% in girls and 15.8% in boys, as being statistically significantly related to at least one pubertal event. Given that the sample sizes of the two prior studies were smaller (51 participants in Denmark and 55 participants in North America) compared to our cohort of 470 adolescents, a low replication proportion is not unusual. Nevertheless, the much lower proportion of replication in boys may be attributed to less obvious markers of puberty in boys than in girls (age at menarche, etc.). However, an argument against this conclusion is that of the work by [@ref77] (30 girls and 25 boys), which is based on clinical measures independent of recall, also identified more significant CpGs in girls (347 CpGs) than in boys (50 CpGs).

Ages at pubertal events are associated with both an increase and decrease in DNAm. In addition, the strength of the identified associations is stronger in girls. The majority of CpGs were associated with age of menarche (*k* = 55 230) in girls and facial hair growth in boys (*k* = 2523), and these events are not included in the Tanner stages ([@ref51]; [@ref52]). The large difference in the number of CpGs in boys and girls may be related to more pronounced pubertal transition in girls compared to boys ([@ref29]) or to differential reporting of ages at puberty. [@ref2]) analyzed data from girls (*n* = 22) and boys (*n* = 32) separately, but only found significant CpGs in boys, which may be due to the larger sample size in boys. The results of our study agree with the work by [@ref77]) (30 girls and 25 boys) that identified more significant CpGs in girls (347 CpGs) than in boys (50 CpGs).

Our statistical approach used repeated measurements of DNAm with differences between age of puberty and the respective DNAm measurement at 10 and 18 years (Δyears) as predictors ([Fig. 1](#f1){ref-type="fig"}). The effect of chronological age was removed, and the residuals of the methylation levels (*M* values) were used. Hence, a positive slope between the time of pubertal events relative to DNAm at ages 10 or 18 years means that the puberty event is related to an increase of DNAm over time. Vice versa, a negative slope described methylation levels that are related to puberty but are higher due to prior experience of puberty and which decrease thereafter. The results show that both processes are related to pubertal markers, a decrease and an increase of methylation over time ([Supplementary Figs S1](#sup1){ref-type="supplementary-material"} and [S2](#sup2){ref-type="supplementary-material"}). The advantage is that a change in methylation was compared to a baseline prior to pubertal events. Our work demonstrates associations between changes in DNAm and various pubertal events; however, we do not claim causal associations since the effects may go in either direction.

Of the 273 replicable CpGs in girls representing 235 genes, three genes (*TCF7---*transcription factor 7, *FTO---*alpha-ketoglutarate dependent dioxygenase, *UBA7---*ubiquitin like modifier-activating enzyme 7) were identified in prior genetic studies and one of the 68 genes representing 67 CpGs was also found in boys (*EVI5L---*ecotropic viral integration site 5 like) ([@ref85]; [@ref17]; [@ref31]; [@ref61]; [@ref63]; [@ref64]; [@ref48]; [@ref5]). The detection of a large number of differently methylated CpGs on various genes in girls and identification of 11 biological processes in girls but none in boys suggests that pubertal changes in girls may be related to physiologically linked developments. It is possible that pubertal processes in boys represent more isolated developmental changes (without important biological pathways).

In boys, concentrating on genes that were associated with ages of at least two pubertal events may increase their biological significance. Of the nine genes included in [Supplementary Table SII](#sup5){ref-type="supplementary-material"}, four were also identified in girls related to multiple pubertal events (*ABI3BP---*ABI family member 3 binding protein \[5\], *DDO---*D-aspartate oxidase \[5\], *HOXB7---*homeobox B7 \[2\] and *KCNAB3---*potassium voltage-gated channel subfamily A regulatory beta subunit 3 \[5\], [Supplementary Table SI](#sup4){ref-type="supplementary-material"}). Gene Ontology annotations related to *ABI3BP* include *heparin* and *glycosaminoglycan binding* (<https://www.genecards.org/>). Heparin-binding proteins (HBPs) originate from secretions of the male accessory glands; seminal plasma contains multiple proteins that bind heparin ([@ref81]). HBPs content decreased in castrated rats and was restored by testosterone replacement ([@ref58]). Epigenetic regulatory actions of *CBX4* (Chromobox 4) seems to be related to feminization of the zebrafish ([@ref70]). *CNTN1* (Contactin 1) encodes the neuronal membrane protein Contactin 1 that functions as a cell adhesion molecule. It was reported that a complex including Contactin is involved in pubertal processes in female rats ([@ref76]). *DDO* (D-aspartate oxidase) encodes a flavoprotein that catalyzes the oxidative deamination of D-aspartate and N-methyl D-aspartate ([@ref74]). D-aspartate seems to operate differently in female and male gonads of frogs ([@ref67]), and the N-methyl D-aspartate receptor has been suggested to play a role during sexual development of male rats ([@ref37]). *ELOVL2* codes a fatty acid elongase 2; this enzyme plays a role in male fertility of Drosophila ([@ref59]). Glutamate metabotropic receptor 2 encoded by *GRM2* plays a role in male sexual performance ([@ref47]). *HOXB7* encodes a nuclear protein that is involved in cell proliferation and differentiation. In mice, mutations of *HOXB7* are related to a delay in urinary tract maturation ([@ref57]). We did not identify any association with puberty for the *KCNAB3* (potassium voltage-gated channel subfamily a regulatory beta subunit 3) and *LIMCH1* (LIM and calponin homology domains 1) genes. However, sex hormones have played a role of *KCNE* (potassium voltage-gated channel subfamily E) potassium channel subunits, which were discovered as hormonally regulated potassium channel components ([@ref23]). Hence, in boys there may be no concerted biological processes. However, a pubertal role for seven of the nine individual genes with replicated CpGs associated with more than one pubertal event cannot be excluded.

A strength of our study is the use of the PDS method to characterize age of pubertal onset. The PDS was developed as a self-report of pubertal growth status. In comparing the self-reported Sexual Maturation Scale (SMS) (developed by Tanner *et al*.) and the PDS, in other studies more missing data resulted from the SMS (13%) than from the PDS (4%) method ([@ref11]). Given a moderate to high concordance between the PDS and physician ratings ([@ref12]; [@ref13]) and difficulties with the acceptance of anatomical drawings in other questionnaires, the PDS was recommended for epidemiological studies ([@ref11]). The PDS approach is also preferable to Tanner SMS methods ([@ref51]; [@ref52]) for obtaining retrospective comprehensive information on the entire pubertal period, since in SMS, the stage of puberty is assigned to the child's current age at the time of data collection. Therefore, if the assessment is not repeated during the whole course of puberty, it only provides a snapshot of pubertal stage at one age. SMS is particularly problematic when assessing age of onset of the growth spurt, because unless serial measurements are taken for a growth curve, it is not possible to ascertain the timing of the growth spurt. As shown in a prior study ([@ref86]), all puberty variables had high internal consistency; the overall raw Cronbach's alpha coefficient was 0.80 in boys and 0.86 in girls. In addition, one advantage of this questionnaire-based study is the replication of epigenetic associations found with clinically assessed data ([@ref2]; [@ref77]), since agreements found between these three approaches indicate that the detected associations do not depend on how the puberty event was measured. This is true in girls, for whom 43.4% of the CpGs identified in our analyses based on questionnaire data were replicated in two studies that used a mixture of laboratory and phenotypic markers of puberty ([@ref2]; [@ref77]). Regarding boys, further research needs to be done to improve the replicability of 15.8%.

A limitation of the repeated measurement model relative to age of pubertal onset is that there is no 'causal' timeline, since earlier DNAm may have affected the pubertal age or the pubertal age may have altered later DNAm. Future studies are recommended that use a baseline at an earlier age that is not close to the changes occurring at puberty. A second limitation is the focus on autosomes. We did not inspect 418 CpGs on the X and Y chromosomes. It is possible that DNAm of the sex chromosome is involved in pubertal development, which, requires additional analyses and other replication data. Hence, we are willing to support investigations into the importance of methylation on the sex chromosomes by sharing data. Our aim was to identify CpGs of genes whose methylation changed from age 10 to 18 years as a consequence of the age at which pubertal markers occurred. We did not attempt to identify DNAm changes subsequent to early or late onset of puberty. Using age of onset of different pubertal markers as continuous measures, we identified DNAm changes that continue from early to late puberty and thus represent the integrated overall effect of puberty. Future studies may also investigate whether the affected genes in women play a role in different disease risks later in life. Also, we did not attempt to replicate the DNAm measurements based on the Illumina 450 K array with other methods, such as pyrosequencing, since this array has been shown to be technically reliable in multiple other studies ([@ref20]; [@ref71]; [@ref27]; [@ref72]; [@ref32]; [@ref1]; [@ref25]; [@ref83]). Finally, the use of nucleated blood cells and not specific tissues is a limitation. However, since there is no ethical way to collect brain or reproductive tissue samples in human, DNA methylation changes in blood cells may provide a window related to pubertal changes in other organs.

Conclusion {#sec10}
==========

In a large birth cohort study with DNA methylation measurement at 10 and 18 years of age, we identified 13 487 CpGs in girls significantly linked with ages of occurrence of all five pubertal events and 311 CpGs in boys. Of these, 273 CpGs in girls and 67 CpGs in boys had been replicated in two other previous investigations. Hence, in girls there are more genes with methylation changes as a consequence of puberty than boys. The affected genes seem to be related to biological processes in bones, adhesion, the neural system, anatomical structure formation and responses to progesterone. Of 303 genes with differential DNA methylation (replicated in other studies) related to puberty in girls and boys, only four genes were known to have genetic polymorphisms associated with puberty. Differential DNAm as a consequence of puberty needs to be investigated in terms of whether these act as mediating factors for adult diseases known to be associated with puberty.
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